CN Stock MarketDetailed Quotes
300529 Jafron Biomedical
- 32.60
- +0.04+0.12%
Trading Nov 15 09:30 CST
26.03BMarket Cap32.37P/E (TTM)
32.89High32.37Low1.25KlotVolume32.57Open32.56Pre Close4.07MTurnover0.02%Turnover Ratio59.60P/E (Static)798.61MShares39.2452wk High8.21P/B16.71BFloat Cap15.5052wk Low39.07Limit Up512.49MShs Float101.06Historical High26.05Limit Down1.60%Amplitude3.15Historical Low0.40Dividend TTM32.62Avg Price546.00lotAsk1.23%Div YieldTTM100Lot Size504.00lotBid
Jafron Biomedical Key Stats
EPS
According to the latest financial report of Jafron Biomedical, the latest earnings per share (TTM) for the company is 0.97. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: CNY
Cumulative Quarterly
Loading...
BVPS
Analyzing a company's fundamentals? Check out Jafron Biomedical's latest financial report to see how much their book value per share (BVPS) is currently at 3.97.
Currency: CNY
Cumulative Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Jafron Biomedical shows that the company's current ratio is 3.77, indicating healthy liquidity.
Currency: CNY
Cumulative Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Jafron Biomedical, the quick ratio is 3.41, indicating that the company can meet its short-term debt obligations.
Currency: CNY
Cumulative Quarterly
Loading...
ROE
Want to learn more about the financial health of Jafron Biomedical? The latest ROE figure is 24.60%, indicating that the company has stable profitability.
Currency: CNY
Cumulative Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Jafron Biomedical, the total asset return on investment (ROA) is 14.17%.
Currency: CNY
Cumulative Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Jafron Biomedical's latest financial report to see how their gross margin is doing - currently at 81.31%.
Currency: CNY
Cumulative Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Jafron Biomedical, the net profit margin is 35.93%, which is a good sign for its profitability.
Currency: CNY
Cumulative Quarterly
Loading...
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
% Chg
No Data